The Provenge Anniversary: A Plea From A Patient
wrote an interesting post today on
Here’s a quick excerpt
The ongoing controversy over the Provenge prostate cancer vaccine is now one year old, and some of the prostate cancer patients and investors in Dendreon, which is developing the vaccine, are commemorating the saga by taking out full-page newspapers ads. The missives, which are sponsored by Care To Live, a non-profit that has filed a lawsuit hoping to compel the FDA to approve Provenge, are aimed squarely at FDA officials, though, because they are running in The Rockville Gazette, the local new
Read the rest of this great post here